IRadimed Corporation

IRMD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$5,577$5,774$4,687$5,147
Dep. & Amort.$384$207$194$195
Deferred Tax$135$134$0-$106
Stock-Based Comp.$0$731$826$657
Change in WC$223$872-$1,492$212
Other Non-Cash$668$28$77-$118
Operating Cash Flow$6,986$7,746$4,292$5,987
Investing Activities
PP&E Inv.-$1,264-$2,636-$3,697-$2,790
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$188-$220-$267
Investing Cash Flow-$1,264-$2,824-$3,917-$3,057
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$26
Stock Repurch.$0$0$0$0
Dividends Paid-$2,163-$2,162-$2,162-$1,901
Other Fin. Act.-$30-$96-$116-$543
Financing Cash Flow-$2,192-$2,258-$2,278-$2,417
Forex Effect$0$0$0$0
Net Chg. in Cash$3,530$2,665-$1,903$513
Supplemental Information
Beg. Cash$52,996$50,331$52,234$51,721
End Cash$56,526$52,996$50,331$52,234
Free Cash Flow$5,848$4,923$595$2,930
IRadimed Corporation (IRMD) Financial Statements & Key Stats | AlphaPilot